Bace1 Inhibitors: A Head Group Scan on a Series of Amides.
Woltering, T.J., Wostl, W., Hilpert, H., Rogers-Evans, M., Pinard, E., Mayweg, A., Gobel, M., Banner, D.W., Benz, J., Travagli, M., Pollastrini, M., Marconi, G., Gabellieri, E., Guba, W., Mauser, H., Andreini, M., Jacobsen, H., Power, E., Narquizian, R.(2013) Bioorg Med Chem Lett 23: 4239
- PubMed: 23735744 
- DOI: https://doi.org/10.1016/j.bmcl.2013.05.003
- Primary Citation of Related Structures:  
4BEK, 4BFD - PubMed Abstract: 
A series of amides bearing a variety of amidine head groups was investigated as BACE1 inhibitors with respect to inhibitory activity in a BACE1 enzyme as well as a cell-based assay. Determination of their basicity as well as their properties as substrates of P-glycoprotein revealed that a 2-amino-1,3-oxazine head group would be a suitable starting point for further development of brain penetrating compounds for potential Alzheimer's disease treatment.
Organizational Affiliation: 
F. Hoffmann-La Roche Ltd., Pharma Research, Grenzacherstr. 124, CH-4070 Basel, Switzerland. thomas.woltering@roche.com